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The Editorial on the Research Topic
Neuronal Self-Defense: Compensatory Mechanisms in Neurodegenerative Disorders
Neurodegenerative diseases (ND) are characterized by the progressive loss of specific neuronal
populations with consequent deterioration of brain’s function. While some ND have monogenic
causes, the vast majority is sporadic. Accordingly, etiology varies greatly between these conditions;
the pathogenesis, however, shares important common traits. Trophic deprivation, oxidative
stress, accumulation of abnormal protein aggregates, and bioenergetics defects have been in fact
described in most, if not all, ND. To counterbalance these noxious stimuli cells deploy intrinsic
neuroprotective responses, at least during early pathogenesis. Adaptation includes strategies to
optimize energetic resources, for instance reduction of rRNA synthesis to repress translation,
suppression of transcription, and bioenergetics and metabolic redesign. Additional mechanisms
include potentiation of antioxidant capacity, induction of endoplasmic reticulum (ER) stress, and
activation of protein quality control systems and autophagy. Strategies to potentiate these naturally
occurring processes might provide foundation to devise new experimental treatments.
This e-book contains a collection of reviews and original articles summarizing the state-of-the-
art knowledge on protective responses sustaining neuronal survival and activity. The ultimate goal
of this work is to inspire novel studies elucidating strategies to contrast these incurable disorders.
The first article reviews transcriptional deregulation inHuntington’s disease (HD). Francelle and
colleagues point out that while transcriptional changes are directly caused by mutant huntingtin,
they may also represent a response to secondary stress conditions triggered by dysfunctional
transcriptional machineries. They speculate that transient expression changes typical of HD may
represent a self-defense mechanism because some of these altered genes activate pro-survival
functions, which may be impaired during aging. Hence, the investigation of gene expression
changes with aging in the striatum, the brain region mostly affected in HD, might help to develop
strategies to modify mutant huntingtin toxicity (Francelle et al.). In line with this concept, Stilling
and colleagues show how aging is associated with changes in gene expression and in RNA splicing,
and with the upregulation of immune system functions in the hippocampus (Stilling et al.).
Interestingly, affected genes are involved in synaptic function, therefore suggesting a potential
pathogenic link between age-dependent transcriptional alterations and late onset of Alzheimer’s
disease (AD) (Stilling et al.).
A second original research article illustrates how two transcription factors important for the
development of dopaminergic neurons also play a role in their maintenance in adulthood. Previous
studies indicated that haploinsufficiency of the transcription factor Foxa 2 leads to abnormalities in
motor behavior in old age and an associated progressive loss of dopaminergic neurons reminiscent
of Parkinson’s disease (PD) (Kittappa et al., 2007). Here Domanskyi and colleagues report that
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Foxa1 and Foxa2 co-evolved to compensate the lack of each
other. By the generation and analysis of specific conditional
double mutant mice they show the protective role of these
transcription factors for the maintenance of dopaminergic
neurons in adult stages (Domanskyi et al.).
A third original article addresses neuronal self defense
mechanisms based on the regulation of rRNA synthesis.
Downregulation of rRNA synthesis has been associated with
neuronal loss in several ND, although disruption of nucleolar
activity may trigger context-specific neuroprotective responses
(Kiryk et al.; Kreiner et al., 2013). The study by Riancho and
colleagues reveals that active nucleolar transcription may be a
compensatory mechanism in a mouse model of amyotrophic
lateral sclerosis (ALS) at both asymptomatic and symptomatic
stages. High rate of rRNA transcription in ALS motor neurons
could maintain protein synthesis when proteostasis is severely
impaired (Riancho et al.).
Edwin Chan reviews aberrant RNA species—an emerging
mechanism of toxicity in ND—particularly in polyQ diseases
linked to nucleotide repeat expansion and in frontotemporal
dementia/ALS (FTD/ALS). The piece discusses the impact of
these mutant RNAs and proposes that toxicity may be ascribed
to alternative splicing of RNAs, hairpin, and double-stranded
CAG repeat RNAs, sequestration of cellular proteins, nucleolar
stress, repeat associated non-ATG translation (RAN-translation)
of CAG expansion transcripts (Chan).
The role of antisense long noncoding RNAs (lncRNAs) as
regulators of neuronal gene expression is rapidly emerging (Ng
et al., 2013). Recent studies indicate that they could contribute
to ND. This mechanism has been for instance demonstrated in
mouse, for the ubiquitin carboxy-terminal hydrolase L1 (Uchl1).
Importantly in human UCHL1 (or PARK5) has been associated
with familial PD. Carrieri and colleagues propose that increasing
its expression might be beneficial and antisense (AS) Uchl 1
could be used to increase Uchl1 mRNA translation. They also
show that AS Uchl 1 promoter region contains a binding site
for Nurr1, a transcription factor required for differentiation of
dopaminergic neurons. Moreover, AS Uchl 1 level is reduced
in the prototypical MPTP model of PD, suggesting that this
novel stress mechanism responding to stress might have a
pathological relevance in PD pathophysiology (Carrieri et al.).
In the context of this post-transcriptional regulation of protein
synthesis, this group also proposes in a second original article the
use of antisense long noncoding RNAs in neuronal cell lines to
activate translation in a gene specific manner (Zucchelli et al.).
Finally, Amadio and colleagues contributed with another original
article on post-transcriptional regulation, proposing that ELAV
(embryonic lethal abnormal vision) proteins to heme-oxygenase-
1 mRNA—a gene activated to counteract oxidative stress—to
increase its expression and elicit neuroprotection with beneficial
effects (Amadio et al.).
After this initial series of articles focusing on transcriptional
and post-transcriptional regulation, the collection continues
with articles discussing compensatory mechanisms based on
translation suppression.
The mammalian (or mechanistic) target of rapamycin
(mTOR) acts as a central regulator of cell homeostasis, and its
activity is tightly regulated (Laplante and Sabatini, 2012). mTOR
plays an important role in neuronal homeostasis (Bateup et al.).
In this context the minireview by Canal and colleagues focuses
on the mTOR inhibitor RTP801/REDD1, a protein encoded by
the stress responsive gene DNA damage inducible transcript
4. REDD1 expression is regulated during development and in
response to DNA damage. In addition, REDD1 is induced by
stressors, such as hypoxia and ER stress. Interestingly REDD1
is also found upregulated in PD. The authors propose a model
in which REDD1 may have either a protective or toxic function
in cell survival depending on its protein level that changes
at different disease stages. At low level, REDD1 might be a
protective compensatory response at early disease stage (Canal
et al.).
The next group of articles deals with accumulation of
protein aggregates, which constitutes another shared mechanism
of neurodegeneration and represents a promising therapeutic
target. The review by Angelika and Fabio Falsone focuses
on different regulators of protein aggregates, including stress
granules (SG) (Falsone and Falsone). SG are dynamic cellular
compartments that contribute to the arrest of mRNA translation
in response to stress insults, such as UV-irradiation, oxidative
stress. SG are also linked to amyloidogenic proteins and
irreversible protein aggregates perturb their normal dynamics.
Alteration of SG dynamics however may be due to irreversible
protein aggregates. The articles also explores the nexus between
heat shock proteins and proteolytic pathways, and specifically
focuses on the crosstalk between different protein degradation
pathways such as ubiquitin-proteasome system, chaperone
mediated autophagy and macroautophagy. The work reveals that
these mechanism share a certain degree of redundancy and the
function of the unaffected one can rescue malfunction of the
other pathways (Falsone and Falsone).
Jaronen and coworkers focus in their review on the role of
ER stress and unfolded protein response (UPR) on the protein
disulfide isomerase (PDI), a chaperone regulator of misfolded
protein degradation, in ALS (Jaronen et al.). PDI is upregulated
in ALS and this upregulation is shown early in the disease
progression in ALS rat models. PDI inactivation increases ER
stress, defined as disruption of the ER linked to accumulation
of misfolded proteins, while at early stages PDI could prevent
aggregation of superoxide dismutase 1 (SOD1). However, at a
later stage increased UPR can result in increased PDI activation
that may result in neurotoxicity by increasing superoxide
production or according to a second model by increasing
hydroperoxyde (Jaronen et al.). A thirdmini-review on this topic,
contributed by Ujval Anilkumar and Jochen Prehn, discusses
non-cell death related functions of anti-apoptotic proteins such
as the pro-survival BCL-2 in mitochondrial physiology and ER
homeostasis (Anilkumar and Prehn). J proteins, which belong
to the chaperone family, may exert neuroprotective effects by
facilitating proteostasis, as also discussed in the mini-review by
Koutras and Braun.
Sugaya and Nagano propose an alternative hypothesis to
explain the variability in the onset of familial ALS (fALS)
despite same SOD1 genetic mutation. Based on available data
for SOD1-linked fALS and a risk-based modeling approach,
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the authors suggest a SOD1 prion-like model of propagation.
Spread of toxic aggregates through cell-to-cell transmission
has been observed in several ND. However, the “protective
aggregation hypothesis” according to which misfolded protein
aggregates may represent a defensive response to protect cells
from more toxic oligomeric species is hypothesized also for
SOD1-linked fALS (Sugaya and Nakano). This article considers
a “one-hit model,” i.e., a mathematical model in which the
risk of cell death remains constant. The next review article by
Fiebich and colleagues, instead, formulates a two-hit hypothesis
that includes also neuroinflammation (Fiebich et al.). Anti-
neuroinflammatory approaches represent a promising strategy
against neurodegeneration and this review discusses the role
of P2 receptors, which can bind ATP released by injured cells.
This represents a second detrimental event synergizing with
aggregation and the possibility of decreasing neuroinflammation
by targeting P2 receptors is accordingly discussed (Fiebich et al.).
In the context of neuroprotective strategies aiming at
potentiating the cell antioxidant capacity, the inhibition of
NMDA receptor and the calcium dependent enzyme nitric
oxide synthase (nNOS) activities is discussed by Courtney
et al. In particular the authors review the role of NOS1AP, an
adaptor protein which is considered a nNOS inhibitor. As a
modulator of the excessive nNOS, NOS1AP may play a role
in the neuronal self-defense against the NMDAR mediated
excitotoxicity dependent on nNOS signaling (Courtney et al.).
Ca2+ overload is a pathogenic feature of sporadic and fALS,
characterized by degeneration of motor neurons (MNs). In this
original article by Mühling and colleagues, pharmacological
stimulation of Ca2+ transporters in this vulnerable neuronal
population is presented as a potential neuroprotective strategy.
The authors show that, in SOD1G93A mice, mitochondrial and
plasma membrane Ca2+ transporters are expressed at higher
levels in MNs dissected from the hypoglossal nucleus. These
findings are in line with an activity dependent Ca2+ clearance
deficit and could represent a compensatory response to the
disease (Mühling et al.).
In the last review closing this e-book, Grzegorz Kreiner
elaborates on the difficulties of modeling ND and arguments that,
despite the unavoidable differences between human and rodents,
compensatory mechanisms shown in mouse models could help
developing new hypotheses to devise neuroprotective strategies
(Kreiner).
We hope that the present e-book provides a better
understanding of mechanisms and their interconnections
regulating neuronal homeostasis, and how ineffective
execution of compensatory strategies severely threatens
cellular homeostasis favoring pathogenesis. We believe that this
comprehensive collection represents an original reference and
may inspire innovative studies that will devise more effective
therapeutic tools to prolong neuronal survival and activity.
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